FEATURED ARTICLES

• 2026 Critical Manufacturing Trends Reshaping Pharma & Medical Device

  Discover how modern life sciences manufacturers integrate digital threads and validated AI frameworks to eliminate operational silos, build supply chain resilience, and upskill the modern workforce.

• Industry Trends: Connecting Quality, Manufacturing, And Asset Management

  Master the shift to CSA and QMSR to reduce validation burdens. Learn to integrate systems and apply AI for predictive quality and operational excellence. Access the strategic roadmap today.

• How Connected Manufacturing Operations And AI Optimize Production

  While 53% of manufacturers are digital, a lack of system connectivity stalls AI progress. Learn how to break down data silos to reduce rework, accelerate quality reviews, and ensure AI readiness.

• 2026 Manufacturing Trends Reshaping Life Sciences

  Explore the manufacturing trends shaping 2026, from AI in validated environments to connected systems and digital workforce readiness that are building more agile, resilient, and compliant operations.

• The Future Of CGT: Integrating Digitalization With Regulatory Readiness

  Explore how cell and gene therapy manufacturers are scaling from batch‑of‑one to commercial supply while staying compliant, digital, and efficient, as well as strategies to strengthen quality.

• Why Compliance-Driven CDMOs Win Sponsor Contracts

  Learn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.

• ICH E6(R3) In Effect: Transforming Quality Management For CGT Trials

  Discover how the updated ICH E6(R3) guideline supports the speed and complexity of CGT manufacturing, enabling flexible, risk‑based decisions and quality systems built to scale therapies safely.

• Building A Scalable Digital Foundation To Support CGT Manufacturing

  Explore how digital systems strengthen CGT manufacturing by improving traceability and managing batch‑of‑one, as well as essential steps toward scalable, integrated operations.

• Not All Manufacturing Automation Is Created Equal

  Learn how outcome-based automation helps life sciences manufacturers reduce risk, improve performance, and drive measurable results—by aligning tools with business goals.

• Streamlining Compliance With AI-Powered Regulatory Intelligence

  Life sciences compliance is complex and ever-changing. Discover how modern solutions can streamline processes, reduce friction, and keep your organization ahead of regulatory demands.

• How To Get Products To Patients Faster With A Connected QMS

  BioBridge Global faced challenges with paper-heavy processes that risked errors and delays. Discover how digital solutions streamlined their operations and improved regulatory efficiency.

• How Compliance-Driven CDMOs Win Sponsor Contracts

  Discover how evolving global regulations are reshaping CDMO strategy. and how digital infrastructure helps manufacturers stay audit-ready, build sponsor trust, and turn compliance into an advantage.

• Modernizing Your Way To Success In Cell And Gene Therapy Manufacturing

  Cell and gene therapy has evolved from a niche concept to a booming sector in just five years, with over 1,300 companies and growing momentum in innovation, investment, and regulatory approvals.

• Ensuring AI Compliance In Life Sciences: 5 Critical Requirements

  Life sciences manufacturers face growing pressure to adopt AI while staying compliant. Discover five key areas to evaluate AI tools and how to simplify adoption with regulatory assurance.

• Digital Maturity In Life Sciences Quality And Manufacturing

  Innovators in life sciences manufacturing drive life-saving breakthroughs. Amid strict regulations and complex challenges, learn how your dedication ensures quality and pushes the boundaries of what’s possible in public health.

• 5 Must-Haves For Electronic Batch Records In Life Sciences

  Companies still relying on paper-based manufacturing are falling behind. Examine how digital transformation boosts efficiency and reduces errors in this essential shift toward smarter operations.

• Digital Transformation In Contract Manufacturing: A Leadership Perspective

  Discover how PCI Pharma Services embraced digital transformation and gain expert insight on overcoming challenges, driving innovation, and maintaining core values in a regulated industry.

• Future-Proofing Life Sciences Manufacturing: 2025 CDMO Trends

  Review contract manufacturing's evolution, driven by technological advancements and regulatory changes, and how CMOs and CDMOs are navigating opportunities and challenges.

• Contract Manufacturing: Must-Know Trends And Strategies For 2025

  Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.

• Revolutionizing Contract Manufacturing With A Unified QMS And MES Platform

  Watch to gain expert insights on utilizing a closed-loop, single-platform approach and explore practical examples and data showcasing the advantages of integrating your QMS and MES.

• 6 Must-Haves For A Quality Management System (QMS)

  Not every quality management system (QMS) has the same capabilities and connectivity. Review several features to take into consideration when selecting a QMS system for your organization.

• A Modern Pharma MES Solution Offers The Best Of Old And New

  What do legacy manufacturing execution systems (MESs) lack? What can a modern pharma MES solution do? Explore the advantages of using a modern MES to evaluate the efficiency of your production line.

• Modernizing Your Cell & Gene Therapy Manufacturing Operations

  What requirements should cell and gene therapy developers meet to successfully bring innovative therapies to market?

• A Guide To Writing Effective SOPs In Life Sciences

  We share some SOP guidelines that can help you build and manage documents that are easily accessible, relevant, and something your team can consistently rely upon.

• The No. 1 Most Common Problem In FDA GMP Inspections

  With issues involving quality responsibilities and procedures at the top of the FDA warning list, we uncover where the solution to make this problem a thing of the past.

• How To Avoid Pharma's Top 5 FDA Form 483 Triggers

  Explore the most commonly cited conditions that led to the issuance of Form 483s last year (summarized by the FDA's most recent 12-month inspection period) and tips for avoiding them.